Algeta ASA, the Norwegian company developing an alpha particle treatment for prostate cancer, has appointed Mike Booth to the newly created role of senior vice president, communications and corporate affairs.
Dr Booth joins Algeta from Trout International in London and will oversee an expansion in the company’s communications and corporate affairs output. He has a PhD in neuropsychology from Oxford University and a background in researching pharmaceutical companies for financial institutions.
Copyright 2011 Evernow Publishing Ltd